Association of high-dose bifonazole administration during early pregnancy and severe limb reduction defects in the newborn.

MLA

Linder, Nehama, et al. “Association of High-Dose Bifonazole Administration during Early Pregnancy and Severe Limb Reduction Defects in the Newborn.” Birth Defects Research. Part A, Clinical and Molecular Teratology, vol. 88, no. 3, Mar. 2010, pp. 201–04. EBSCOhost, https://doi.org/10.1002/bdra.20644.

APA

Linder, N., Amarilla, M., Hernandez, A., Tamiri, T., Sirota, L., Klinger, G., Levy, I., & Merlob, P. (2010). Association of high-dose bifonazole administration during early pregnancy and severe limb reduction defects in the newborn. Birth Defects Research. Part A, Clinical and Molecular Teratology, 88(3), 201–204. https://doi.org/10.1002/bdra.20644

Chicago

Linder, Nehama, Mandola Amarilla, Adriana Hernandez, Tsippy Tamiri, Lea Sirota, Gil Klinger, Itzhak Levy, and Paul Merlob. 2010. “Association of High-Dose Bifonazole Administration during Early Pregnancy and Severe Limb Reduction Defects in the Newborn.” Birth Defects Research. Part A, Clinical and Molecular Teratology 88 (3): 201–4. doi:10.1002/bdra.20644.